Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Cancer Research
|
April 17, 2004
The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors
Ling Wang, Naohiro Wakisaka, Christine C Tomlinson, et al.
Molecular Pharmacology
|
May 26, 2011
Quantifying ligand bias at seven-transmembrane receptors
Sudarshan Rajagopal, Seungkirl Ahn, David H Rominger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 11, 2007
A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling
James W Wisler, Scott M DeWire, Erin J Whalen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 31, 2010
Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance
Jonathan D Violin, Scott M DeWire, Dennis Yamashita, et al.
Circulation Research
|
June 4, 2008
Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration
Jihee Kim, Lisheng Zhang, Karsten Peppel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 22, 2016
Unexpected Potency Differences between B-Cell-Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
Amy M Nicoletti, Cynthia Hess Kenny, Ashraf M Khalil, et al.
The Journal of Clinical Investigation
|
April 8, 2009
beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice
Robert W Walters, Arun K Shukla, Jeffrey J Kovacs, et al.
Journal of Medicinal Chemistry
|
September 26, 2013
Structure-activity relationships and discovery of a G protein biased μ opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain
Xiao-Tao Chen, Philip Pitis, Guodong Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2013
A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine
Scott M DeWire, Dennis S Yamashita, David H Rominger, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Cancer Research
|
April 17, 2004
The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors
Ling Wang, Naohiro Wakisaka, Christine C Tomlinson, et al.
Molecular Pharmacology
|
May 26, 2011
Quantifying ligand bias at seven-transmembrane receptors
Sudarshan Rajagopal, Seungkirl Ahn, David H Rominger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 11, 2007
A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling
James W Wisler, Scott M DeWire, Erin J Whalen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 31, 2010
Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance
Jonathan D Violin, Scott M DeWire, Dennis Yamashita, et al.
Circulation Research
|
June 4, 2008
Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration
Jihee Kim, Lisheng Zhang, Karsten Peppel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 22, 2016
Unexpected Potency Differences between B-Cell-Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
Amy M Nicoletti, Cynthia Hess Kenny, Ashraf M Khalil, et al.
The Journal of Clinical Investigation
|
April 8, 2009
beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice
Robert W Walters, Arun K Shukla, Jeffrey J Kovacs, et al.
Journal of Medicinal Chemistry
|
September 26, 2013
Structure-activity relationships and discovery of a G protein biased μ opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain
Xiao-Tao Chen, Philip Pitis, Guodong Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2013
A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine
Scott M DeWire, Dennis S Yamashita, David H Rominger, et al.
Page
of 2